Author

Lijuan Fang

Institution: Wuhan YZY Biopharma (China)

Observed institution: Wuhan YZY Biopharma (China)

OpenAlex ID: A5124106981

Universal broad-spectrum mucosal vaccine design for human coronaviruses inspired by artificial antibodies

2026 · Yan Wu, Jia Lu, et al. · npj Vaccines · 3

Targeted FcRn to deliver epitope-optimized RBD confers broad-spectrum mucosal protection against SARS-CoV-2

2026 · Xinlan Chen, Yan Wu, et al. · Molecular Therapy — Nucleic Acids

Works count: 2

Citation count: 3

H-index: 1

I10-index: